From the story:

The study “was not a rigorous experiment” and “has not been reviewed by other scientists.”

“The difference between [the group that received the drug] and usual care was not considered large enough to rule out other factors that could have affected survival.” https://twitter.com/politico/status/1252655966895640577

There’s a strange culture war skirmish around this drug, with many people (definitely including journalists) weirdly invested in its effectiveness in treating Coronavirus, basically as a proxy for loving or hating Trump (not Cuomo, or anyone else who’s been optimistic).

We know that some people directly attribute their recovery to it. We know that some smaller (also flawed) tests have been more positive. We should wait for the wider clinical trials before reaching strong conclusions.

As a layperson observer who’s watched this battle play out, I wouldn’t be surprised if it turns out that it’s a mixed bag: Helpful for some, neutral for others, potentially dangerous for others susceptible to certain side effects.